Endometrial (uterine) cancer is the most common gynecologic cancer, and many cases are found early and are highly treatable. Our oncologists coordinate any chemotherapy, targeted therapy, or immunotherapy with your gynecologic and surgical team.
How we approach it
Because it usually causes abnormal bleeding, endometrial cancer is frequently found at an early, treatable stage
Tumor testing can open targeted and immune treatment options, especially for advanced disease
Surgery is often the main treatment; we coordinate any added therapy around it
What the workup looks like
Abnormal bleeding usually leads to an endometrial biopsy, which most often makes the diagnosis.
A hysterectomy is typically both the main treatment and the way the cancer is staged.
Tumor features and molecular testing determine whether radiation or chemotherapy is recommended afterward.
Radiation therapy for uterine and endometrial cancer
Radiation therapy is one of the tools we may use in treating uterine and endometrial cancer — sometimes after surgery to lower the risk of the cancer returning. When it’s part of your plan, it’s delivered with the advanced TrueBeam® system and planned by our board-certified radiation oncologist, Dr. Dan Ishihara, working hand-in-hand with your medical oncologist so radiation, drug therapy, and surgery come together as one plan rather than three.
Common questions
What's the most common symptom?
Will I need chemotherapy?
Does tumor testing change treatment?
Is endometrial cancer usually curable?
This page is general information, not medical advice for your specific situation. Every diagnosis — and every patient — is different. Bring your questions to your care team.